Table 1 HCPs’ characteristics
Characteristic | Whole sample | Allergologists | ENTs | GPs | p value |
|---|---|---|---|---|---|
N = 350 | N = 100 | N = 100 | N = 150 | ||
Age, years | 56.9 ± 8.2 | 53.47 ± 10.91 | 55.60 ± 7.80 | 60.28 ± 5.40 | < 0.001 |
Clinical experience, years | 27.7 ± 9.4 | 24.48 ± 11.10 | 27.28 ± 8.65 | 30.14 ± 7.92 | < 0.001 |
Geographic area | – | ||||
Northwest Italy | 86 (24.5%) | 25 (7.1%) | 24 (6.8%) | 37 (10.5%) | |
Northeast Italy | 60 (17.1%) | 14 (4%) | 19 (5.4%) | 27 (7.7%) | |
Central | 78 (22.2%) | 25 (7.1%) | 21 (6%) | 32 (9.1%) | |
South and Insular Italy | 126 (36%) | 36 (10.2%) | 36 (10.2%) | 54 (15.4%) | |
Patients volume/month | 210 [100–400] | 150 [100–247] | 150 [100–300] | 400 [300–500] | < 0.001 |
AR patients volume/month | 20 [12–50] | 40 [20–80] | 21 [14–50] | 18 [10–30] | < 0.001 |
% of new diagnosis/month | 33.4 ± 25.3 | 45.3 ± 24.7 | 42.1 ± 25.4 | 19.6 ± 18.0 | < 0.001 |
Prescription drivers | |||||
Quick symptom relief | 8.9 ± 1.2 | 9.0 ± 1.2 | 8.9 ± 1.3 | 8.8 ± 1.3 | 0.490 |
Effective with few drugs | 8.8 ± 1.3 | 9.9 ± 1.0 | 8.7 ± 1.5 | 8.7 ± 1.4 | 0.219 |
Effective on all AR symptoms | 9.1 ± 1.1 | 9.4 ± 0.9 | 9.1 ± 1.1 | 9.1 ± 1.3 | 0.101 |
Sustained efficacy | 8.9 ± 1.1 | 8.9 ± 1.1 | 9.0 ± 1.2 | 8.9 ± 1.3 | 0.819 |
Few/no side effects | 9.1 ± 1.0 | 9.3 ± 1.1 | 9.2 ± 1.1 | 9.1 ± 1.0 | 0.373 |
Supported by scientific literature | 8.6 ± 1.4 | 8.9 ± 1.5 | 8.7 ± 1.3 | 8.5 ± 1.4* | 0.043 |
Easy to take | 8.5 ± 1.4 | 8.7 ± 1.3 | 8.4 ± 1.9 | 8.6 ± 1.3 | 0.434 |
Increased patient adherence | 8.8 ± 1.2 | 8.9 ± 1.2 | 8.9 ± 1.4 | 8.8 ± 1.1 | 0.794 |
Refundable | 6.8 ± 2.5 | 7.5 ± 2.6 | 5.7 ± 2.9*# | 7.2 ± 2.1 | < 0.001 |
Affordable price | 8.1 ± 1.7 | 8.4 ± 1.6 | 7.9 ± 0.2 | 8.2 ± 0.1 | 0.128 |